마크로젠 로고
macrogen
Service
newsroom
ir
esg
Contact Us
KOR
Company
About MACROGEN
Executive Leadership
History
Vision
Certification & Accreditation
Global Network
Resource
Patents
Papers
R&D
Precision Medicine Institute
Bioinformatics Institute
Personal Healthcare
Disease Prediction
& Wellness Genetic Test
DTC Genetic Testing
Pet Healthcare
Pet DNA Test
Research Services
NGS
Whole Genome Sequencing
Whole Exome Sequencing
Transcriptome Sequencing
Epigenome Sequencing
Metagenome Sequencing
CES
Standard Sequencing
Identification
Fragment
Customized Sequencing
Human ID
Microarray
Expression Microarray
Genome Microarray
Epigenome Microarray
Proteomics
Proteomics Olink
Gene Synthesis
Oligo
DNA Oligo Synthesis
RNA Oligo Synthesis
Peptide Synthesis
GEM/CRISPR
CRISPR Knock-in/out
GEM
Mass Production
Additional
Clinical Services
Precision Medicine
Cancer risk prediction
Analysis of causes of
cancer
Cancer Occurrence
Monitoring
Genetic testing
for cancer risk
Cancer Panel
Hereditary Cancer Panel
BRCA1/2 Cancer Panel
Gastric Cancer Panel
NGS-based Genetic
Panel Lab
Certification acquired by
Macrogen in the clinical
diagnosis business
Key features and strengths
of Macrogen’s cancer panels
Scope of projects to set up
NGS-based PMG labs
GCLP
ClinPham Seq
Multi Omics
Storage of samples
Single Cell Expert Services
Single Cell Multi-omics Analysis
Spatial Transcriptome Analysis
Single Cell (In situ / Spatial)
News
Notice
Financial Information
Investment Inquiries
ESG Management
Ethical Management
Social Responsibility
Greenhouse gas emissions
Privacy Statement
2021. 08. 02 ~ Present
2021.08.02 ~ Present
2021.08.01 ~ Present
개인정보처리방침 영문 version 2
개인정보처리방침 영문 version 2
개인정보처리방침 영문 version 2
TOP